Taiwan Liposome Company
Dr. Dalal has served on our board of directors since September 2017. He is currently Chief Investment Officer at Acuta Capital Partners, LLC, an investment management services firm. Prior to joining Acuta Capital in 2016, Dr. Dalal was the Managing Director of Kearny Venture Partners, a healthcare investment firm, from 2006 to 2016. Dr. Dalal founded and was a managing member of KVP Capital GP, LLC, a venture capital firm, from 2013 to 2016, and was a principal at Flagship Pioneering, a private equity and venture capital firm, from 2002 to 2006. Dr. Dalal also serves on the board of directors of Aerpio Pharmaceuticals, Inc. (formerly Aerpio Therapeutics, Inc.), a publicly traded biopharmaceutical company. Dr. Dalal received an M.D. from the University of California, San Francisco, an M.B.A. from Harvard Business School, and a B.A. in Economics from the University of California, Berkeley.
Pharma, Clinical research, Pharmaceutical sciences